These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 302643)

  • 21. Z and S mutations of the alpha1-antitrypsin gene and the risk of chronic obstructive pulmonary disease.
    Sandford AJ; Weir TD; Spinelli JJ; Paré PD
    Am J Respir Cell Mol Biol; 1999 Feb; 20(2):287-91. PubMed ID: 9922220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: No statistical refuge for the alpha1 antitrypsin-deficient smoker.
    Moser KM
    JAMA; 1975 Feb; 231(6):625-7. PubMed ID: 1078703
    [No Abstract]   [Full Text] [Related]  

  • 23. Coal mining and COPD.
    Morgan WK
    Thorax; 1999 Feb; 54(2):187. PubMed ID: 10325930
    [No Abstract]   [Full Text] [Related]  

  • 24. Risk factors in chronic obstructive pulmonary disease (COPD).
    Cohen BH; Ball WC; Brashears S; Diamond EL; Kreiss P; Levy DA; Menkes HA; Permutt S; Tockman MS
    Am J Epidemiol; 1977 Mar; 105(3):223-32. PubMed ID: 300564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pilot detection study of alpha(1) antitrypsin deficiency in a targeted population.
    Fleming LE; Oquendo S; Bean JA; Tamer R; Finn S; Wanner A
    Am J Med Genet; 2001 Sep; 103(1):69-74. PubMed ID: 11562937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic obstructive pulmonary disease in two cities of contrasting air quality.
    Neri LC; Mandel JS; Hewitt D; Jurkowski D
    Can Med Assoc J; 1975 Dec; 113(11-12):1043-6. PubMed ID: 1201540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical, epidemiologic, and pulmonary function studies in alpha,-antitrypsin-deficient subjects of Pi Z type.
    Rawlings W; Kreiss P; Levy D; Cohen B; Menkes H; Brashears S; Permutt S
    Am Rev Respir Dis; 1976 Nov; 114(5):945-53. PubMed ID: 1086622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inherited risk factors for chronic lung disease.
    Madison R; Zelman R; Mittman C
    Chest; 1980 Feb; 77(2 Suppl):255-7. PubMed ID: 6965632
    [No Abstract]   [Full Text] [Related]  

  • 29. [Homozygous alpha 1-antitrypsin deficiency. Lung changes in children and adolescents].
    Paul K; Niggemann B
    Monatsschr Kinderheilkd; 1993 May; 141(5):395-400. PubMed ID: 8326958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological studies in a large sibship with antitrypsin deficiency.
    Duncan PE; Griffin JP
    Br J Dis Chest; 1975 Apr; 69(2):107-17. PubMed ID: 49190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutation in the 3' region of the alpha-1-antitrypsin gene and chronic obstructive pulmonary disease.
    Sandford AJ; Spinelli JJ; Weir TD; Paré PD
    J Med Genet; 1997 Oct; 34(10):874-5. PubMed ID: 9350828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of abnormal protease inhibitor phenotypes in patients with chronic obstructive lung disease.
    Mittman C; Lieberman J; Rumsfeld J
    Am Rev Respir Dis; 1974 Feb; 109(2):295-6. PubMed ID: 4811786
    [No Abstract]   [Full Text] [Related]  

  • 33. Longterm study of development of chronic obstructive diseases in patients treated in hospital. Evaluation of some functional parameters.
    Acketa M; Tabori D; Goldman S
    Bronchopneumologie; 1980; 30(5):382, 385-7. PubMed ID: 7459645
    [No Abstract]   [Full Text] [Related]  

  • 34. A family study of the variability of pulmonary function in alpha 1-antitrypsin deficiency. Quantitative phenotypes.
    Silverman EK; Province MA; Rao DC; Pierce JA; Campbell EJ
    Am Rev Respir Dis; 1990 Nov; 142(5):1015-21. PubMed ID: 2240821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In-depth and general study in a North American rural community of the host-related factors in subjects with chronic obstructive lung diseases: genetic characteristics].
    Miller R; Kueppers F; Hepper NG
    Bull Int Union Tuberc; 1976; 51(1 Pt 2):667-9. PubMed ID: 83172
    [No Abstract]   [Full Text] [Related]  

  • 36. Heterozygosity in the Pi-system as a pathogenetic cofactor in chronic obstructive pulmonary disease (COPD).
    Bartmann K; Fooke-Achterrath M; Koch G; Nagy I; Schütz I; Weis E; Zierski M
    Eur J Respir Dis; 1985 Apr; 66(4):284-96. PubMed ID: 3874784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A genetic-epidemiologic study of chronic obstructive pulmonary disease. I. Study design and preliminary observations.
    Cohen BH; Ball WC; Bias WB; Brashears S; Chase GA; Diamond EL; Hsu SH; Kreiss P; Levy DA; Menkes HA; Permutt S; Tockman MS
    Johns Hopkins Med J; 1975 Sep; 137(3):95-104. PubMed ID: 1081163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occupational exposure to dust and lung disease among sheet metal workers.
    Hunting KL; Welch LS
    Br J Ind Med; 1993 May; 50(5):432-42. PubMed ID: 8507596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Roentgenographic study of chronic obstructive pulmonary disease by alpha1-antitrypsin phenotype.
    Hepper NG; Muhm JR; Sheehan WC; Kueppers F; Offord KP
    Mayo Clin Proc; 1978 Mar; 53(3):166-72. PubMed ID: 304949
    [No Abstract]   [Full Text] [Related]  

  • 40. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.
    Saetta M; Di Stefano A; Turato G; Facchini FM; Corbino L; Mapp CE; Maestrelli P; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):822-6. PubMed ID: 9517597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.